Thread regarding Moderna Therapeutics (MRNA)

Stock's up 21% to start the year, trading around $42. Finally some relief after getting hammered last year. The whole rally is about their cancer vaccine with Merck. They've got trials going for melanoma and lung cancer, potential launch next year. That's what has me hopeful. But analysts are saying the trial results could either send this up 50% or cut it in half. Plus they're still burning through billions in cash every year. So it's basically a gamble on whether the cancer dr-g works out. I'm holding for now, but this could go either way.